Norman Stockbridge Selected Research

Norman Stockbridge Research Topics

Disease

13	Heart Failure 12/2022 - 04/2014
6	Hemorrhage 01/2021 - 06/2015
5	Stroke (Strokes) 01/2021 - 05/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2015
3	Hypotension (Low Blood Pressure) 01/2019 - 01/2016
3	Torsades de Pointes (Torsade de Pointes) 01/2017 - 03/2014
3	Hypertension (High Blood Pressure) 10/2014 - 08/2012
2	Vascular Diseases (Vascular Disease) 01/2021 - 01/2017
2	Embolism (Embolus) 01/2021 - 11/2020
2	Chronic Renal Insufficiency 01/2021 - 01/2021
2	Atrial Fibrillation 11/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 11/2020 - 12/2019
2	Shock 01/2019 - 01/2019
2	AIDS-Related Complex (ARC) 01/2019 - 01/2019
2	Pulmonary Hypertension 01/2017 - 02/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2020
1	Myocardial Infarction 12/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Hemorrhagic Stroke 01/2018
1	Ischemic Stroke 01/2018
1	Hyperkalemia 08/2016
1	Pulmonary Arterial Hypertension 02/2016
1	Cardiotoxicity 01/2016
1	Acute Coronary Syndrome 10/2015
1	Long QT Syndrome 04/2015
1	Atherosclerosis 03/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2008

Drug/Important Bio-Agent (IBA)

4	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 05/2008
2	AnticoagulantsIBA 01/2021 - 06/2015
2	Dabigatran FDA Link 01/2021 - 11/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	Sodium-Glucose Transport ProteinsIBA 11/2020 - 12/2019
2	Angiotensin IIIBA 01/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 02/2016 - 10/2015
2	Ion Channels (Ion Channel)IBA 01/2016 - 04/2015
1	Loperamide (Imodium)FDA LinkGeneric 01/2023
1	Diphenoxylate FDA LinkGeneric 01/2023
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Nonprescription Drugs (Patent Medicines)IBA 01/2023
1	mitragynineIBA 01/2023
1	Naltrexone (ReVia)FDA LinkGeneric 01/2023
1	Methadone (Dolophine)FDA LinkGeneric 01/2023
1	Neprilysin (Neutral Endopeptidase)IBA 11/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2021
1	candesartanIBA 11/2021
1	Factor Xa InhibitorsIBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	apixabanIBA 01/2021
1	edoxabanIBA 01/2021
1	SodiumIBA 01/2021
1	vorapaxarIBA 11/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2020
1	Prasugrel Hydrochloride FDA Link 11/2020
1	AntithrombinsIBA 11/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019
1	CatecholaminesIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	N(4)-oleylcytosine arabinosideIBA 01/2018
1	Drug CombinationsIBA 01/2017
1	3-(2-carboxyindol-3-yl)propionic acidIBA 01/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	PotassiumIBA 08/2016
1	AldosteroneIBA 08/2016
1	ReninIBA 08/2016
1	AngiotensinsIBA 08/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2016
1	Cardiovascular AgentsIBA 04/2015
1	Potassium Channels (Potassium Channel)IBA 04/2015
1	SilverIBA 03/2014
1	Amlodipine (Norvasc)FDA LinkGeneric 08/2012
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 08/2012
1	Valsartan (Vals)FDA Link 08/2012
1	aliskiren FDA Link 08/2012

Therapy/Procedure

16	Therapeutics 12/2022 - 03/2008
3	Percutaneous Coronary Intervention 01/2020 - 01/2019
2	Precision Medicine 01/2017 - 10/2015
1	Transcatheter Aortic Valve Replacement 11/2020
1	Contraindications 01/2018
1	Microelectrodes 01/2017